OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants
Manon Vogrig, Anne‐Emmanuelle Berger, Thomas Bourlet, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 1, pp. 31-45
Open Access | Times Cited: 8
Manon Vogrig, Anne‐Emmanuelle Berger, Thomas Bourlet, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 1, pp. 31-45
Open Access | Times Cited: 8
Showing 8 citing articles:
Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicity
Kyuto Sonehara, Yoshifumi Uwamino, Ryunosuke Saiki, et al.
Cell Genomics (2025), pp. 100783-100783
Open Access
Kyuto Sonehara, Yoshifumi Uwamino, Ryunosuke Saiki, et al.
Cell Genomics (2025), pp. 100783-100783
Open Access
Combining SARS‐CoV‐2 interferon‐gamma release assay with humoral response assessment to define immune memory profiles
William Mouton, Guy Oriol, Christelle Compagnon, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 7
Closed Access | Times Cited: 2
William Mouton, Guy Oriol, Christelle Compagnon, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 7
Closed Access | Times Cited: 2
Impact of SARS-CoV-2 Vaccine and Infection History on Antiviral Immunity Post Breakthrough Infection
Carla Saade, Timothée Bruel, Lou-Léna Vrignaud, et al.
(2024)
Closed Access | Times Cited: 1
Carla Saade, Timothée Bruel, Lou-Léna Vrignaud, et al.
(2024)
Closed Access | Times Cited: 1
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals
Roberto Lozano‐Rodríguez, José Avendaño‐Ortiz, Verónica Terrón, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Roberto Lozano‐Rodríguez, José Avendaño‐Ortiz, Verónica Terrón, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants
Marta Fernández‐González, Vanesa Agulló, José Alberto García, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 9, pp. 1240-1252
Open Access | Times Cited: 3
Marta Fernández‐González, Vanesa Agulló, José Alberto García, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 9, pp. 1240-1252
Open Access | Times Cited: 3
Interferon-γ Release Assay in the Assessment of Cellular Immunity—A Single-Centre Experience with mRNA SARS-CoV-2 Vaccine in Patients with Juvenile Idiopathic Arthritis
Katarzyna Kapten, Krzysztof Orczyk, Anna Maeser, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2523-2523
Open Access
Katarzyna Kapten, Krzysztof Orczyk, Anna Maeser, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2523-2523
Open Access
Immune Response and Transplacental Antibody Transfer in Pregnant Women after COVID-19 Vaccination
Chiara Lubrano, Alessandro Mancon, Gaia Maria Anelli, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 4, pp. 689-689
Open Access | Times Cited: 1
Chiara Lubrano, Alessandro Mancon, Gaia Maria Anelli, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 4, pp. 689-689
Open Access | Times Cited: 1
QuantiFERON Sars-CoV-2
Chantal Bertholom
Option/Bio (2023) Vol. 34, Iss. 675-676, pp. 17-17
Closed Access
Chantal Bertholom
Option/Bio (2023) Vol. 34, Iss. 675-676, pp. 17-17
Closed Access
